Your browser doesn't support javascript.
loading
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.
Kozlovskaya, Liubov I; Piniaeva, Anastasia N; Ignatyev, Georgy M; Gordeychuk, Ilya V; Volok, Viktor P; Rogova, Yulia V; Shishova, Anna A; Kovpak, Anastasia A; Ivin, Yury Yu; Antonova, Liliya P; Mefyod, Kirill M; Prokosheva, Lyubov S; Sibirkina, Anna S; Tarasova, Yuliya Yu; Bayurova, Ekaterina O; Gancharova, Olga S; Illarionova, Victoria V; Glukhov, Grigory S; Sokolova, Olga S; Shaitan, Konstantin V; Moysenovich, Anastasia M; Gulyaev, Stanislav A; Gulyaeva, Tatiana V; Moroz, Andrey V; Gmyl, Larissa V; Ipatova, Elena G; Kirpichnikov, Mikhail P; Egorov, Alexey M; Siniugina, Aleksandra A; Ishmukhametov, Aydar A.
Afiliação
  • Kozlovskaya LI; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Piniaeva AN; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Ignatyev GM; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Gordeychuk IV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Volok VP; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Rogova YV; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Shishova AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Kovpak AA; Department of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Ivin YY; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Antonova LP; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Mefyod KM; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Prokosheva LS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Sibirkina AS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Tarasova YY; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Bayurova EO; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Gancharova OS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Illarionova VV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Glukhov GS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Sokolova OS; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Shaitan KV; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Moysenovich AM; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Gulyaev SA; Department of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Gulyaeva TV; Department of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Moroz AV; Department of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Gmyl LV; Department of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Ipatova EG; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Kirpichnikov MP; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Egorov AM; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Siniugina AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
  • Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.
Emerg Microbes Infect ; 10(1): 1790-1806, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34427172

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas de Produtos Inativados / Imunidade Humoral / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas de Produtos Inativados / Imunidade Humoral / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article